About Pedro Beltran
Pedro Beltran is a president and CEO, director at BridgeBio Oncology Therapeutics.
Form D filings name Pedro Beltran as an executive officer at TheRas.
Pedro Beltran reports to the SEC as a director or officer of 1 public company.
Pedro Beltran first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Pedro Beltran in the role, so the role may have started earlier or lasted longer.
BI
BridgeBio Oncology Therapeutics, Inc.
President and CEO, director
2025 – 2026 · Public company (BBOT)
Key Colleagues at Startups
The people Pedro Beltran works with at each company, as listed on that company's latest Form D.
TheRas, Inc. · Form D, May 15, 2024
MD
Michelle Doig
Director
IE
Idan Elmelech
Executive officer
FM
Frank McCormick
Director
NK
Neil Kumar
Director
EW
Eli Wallace
CEO
RK
Raymond Kelleher
Director